Psagot Investment House Ltd. Has $132,000 Stake in Spectrum Pharmaceuticals, Inc. (SPPI)

Psagot Investment House Ltd. Has $132,000 Stake in Spectrum Pharmaceuticals, Inc. (SPPI)

Psagot Investment House Ltd. held its position in shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) during the fourth quarter, Holdings Channel reports. The institutional investor owned 29,886 shares of the biotechnology company’s stock at the end of the fourth quarter. Psagot Investment House Ltd.’s holdings in Spectrum Pharmaceuticals were worth $132,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. California Public Employees Retirement System increased its position in shares of Spectrum Pharmaceuticals by 0.4% in the second quarter. California Public Employees Retirement System now owns 179,800 shares of the biotechnology company’s stock valued at $1,181,000 after buying an additional 800 shares during the period. Profund Advisors LLC boosted its stake in shares of Spectrum Pharmaceuticals by 5.2% in the second quarter. Profund Advisors LLC now owns 16,381 shares of the biotechnology company’s stock valued at $108,000 after buying an additional 817 shares in the last quarter. BlackRock Inc. boosted its stake in shares of Spectrum Pharmaceuticals by 2.6% in the third quarter. BlackRock Inc. now owns 34,464 shares of the biotechnology company’s stock valued at $161,000 after buying an additional 859 shares in the last quarter. Comerica Bank boosted its stake in shares of Spectrum Pharmaceuticals by 1.7% in the second quarter. Comerica Bank now owns 60,743 shares of the biotechnology company’s stock valued at $429,000 after buying an additional 1,036 shares in the last quarter. Finally, Quantitative Systematic Strategies LLC boosted its stake in shares of Spectrum Pharmaceuticals by 4.3% in the second quarter. Quantitative Systematic Strategies LLC now owns 24,942 shares of the biotechnology company’s stock valued at $164,000 after buying an additional 1,039 shares in the last quarter. Institutional investors own 70.49% of the company’s stock.

Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) traded down 1.09% during mid-day trading on Friday, reaching $4.53. 129,868 shares of the company were exchanged. Spectrum Pharmaceuticals, Inc. has a 12 month low of $3.21 and a 12 month high of $7.74. The company’s market capitalization is $359.24 million. The firm’s 50-day moving average is $4.54 and its 200-day moving average is $4.95.

Spectrum Pharmaceuticals (NASDAQ:SPPI) last issued its quarterly earnings results on Monday, November 14th. The biotechnology company reported ($0.22) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.30) by $0.08. Spectrum Pharmaceuticals had a negative net margin of 34.19% and a negative return on equity of 13.92%. On average, equities analysts forecast that Spectrum Pharmaceuticals, Inc. will post ($1.02) earnings per share for the current fiscal year.

Several analysts have recently issued reports on the stock. HC Wainwright reissued a “buy” rating and set a $10.00 price objective on shares of Spectrum Pharmaceuticals in a research note on Friday, November 4th. Zacks Investment Research cut shares of Spectrum Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Friday, October 28th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. Spectrum Pharmaceuticals presently has a consensus rating of “Hold” and a consensus price target of $8.10.

Spectrum Pharmaceuticals Company Profile

Spectrum Pharmaceuticals, Inc is a biotechnology company. The Company operates through developing and commercializing oncology and hematology drug products segment. It has approximately six approved oncology/hematology products that target different types of non-Hodgkin’s lymphoma (NHL), metastatic colorectal cancer, acute lymphoblastic leukemia (ALL) and multiple myeloma (MM).

Want to see what other hedge funds are holding SPPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI).

Related posts

Leave a Comment